Company Overview
Agape ATP Corporation functions as an investment holding company dedicated to the supply of health and wellness products alongside the provision of health solution advisory services specifically within the Malaysian market. The organization operates through distinct segments focused on skin care, health and wellness, and green energy, offering a series of programs that encompass various services. This entity is classified within the Consumer Defensive sector and the Packaged Foods industry, positioning it as a provider of essential goods that theoretically maintain demand regardless of broader economic fluctuations. The company maintains a relatively small operational scale with a market capitalization of $3.20M, annual revenue of $1.48M, and an employee base of 16 individuals. These financial metrics indicate that Agape ATP Corporation operates as a micro-cap entity with limited market penetration and minimal revenue generation relative to established peers in the consumer defensive space.
Financial Health
The company reported a trailing twelve-month revenue of $1.48M, yet this generated a net income of $-2,711,293 and an EBITDA of $-2,724,867, revealing a significant structural gap where operating expenses vastly exceed total sales. This disparity between positive revenue and substantial negative net income highlights a cost structure where overhead, administrative costs, or segment-specific losses are consuming the entire operating profit before interest and taxes. The free cash flow stands at $-1,193,122, indicating that the company is burning cash rather than generating liquidity, which suggests limited financial flexibility to fund organic growth or weather economic downturns without external financing. Despite these operational losses, the balance sheet retains $23.13M in cash against only $247,807 in debt, creating a unique financial profile where liquidity assets dwarf liabilities. The debt-to-equity ratio of 1.09 further contextualizes the leverage, while the massive cash reserve suggests the company is not currently in a distressed debt situation but rather faces profitability challenges. The current ratio is an exceptionally high 16.21, which indicates robust short-term liquidity and an ability to cover short-term obligations many times over, though such a high figure often points to idle assets or inventory valuation issues. Return on Equity is recorded at -21.6% and Return on Assets at -12.4%, metrics that reveal management is currently failing to generate positive returns on the capital invested in the business or the assets held on the balance sheet.
Valuation Assessment
The trailing P/E ratio and forward P/E are both listed as N/A, a valuation anomaly that implies earnings are currently negative and therefore precludes the use of traditional earnings-based valuation multiples. Consequently, the price-to-book ratio of 0.14 indicates that the market is valuing the company at less than one-fifth of its book value, suggesting significant market skepticism or a perception that the asset base does not reflect current earning potential. The price-to-sales ratio is 2.16, while the EV/EBITDA stands at 7.24; these alternative metrics suggest the market is pricing the stock based on sales volume rather than profitability, potentially reflecting high growth expectations or a discount due to the lack of earnings. The 52-week high is $128.25 and the 52-week low is $1.72, meaning the current price sits extremely close to the bottom of this massive range, specifically trading at approximately 98.7% below the 52-week high. The beta value is 0.28, which indicates that the stock's price volatility is significantly lower than the broader market, moving only about 28% as much as the overall index during periods of market fluctuation.
Growth & Income
Revenue growth year-over-year is 11.9%, whereas earnings growth is N/A due to the negative net income, implying that while sales are expanding, the bottom line remains deeply in the red and earnings are not growing in a traditional sense. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the firm is retaining all cash flow rather than distributing it to shareholders. Since the payout ratio is zero and the company is not a dividend payer, the company reinvests any available capital or relies on external funding to support its operations and the green energy or skin care segments. The overall growth and income profile is characterized by positive top-line expansion coupled with persistent operational losses and a complete absence of dividend income for investors.